Allspring Global Investments’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-38,146
Closed -$478K – 2526
2024
Q1
$478K Buy
38,146
+7,327
+24% +$94.7K ﹤0.01% 1541
2023
Q4
$473K Sell
30,819
-5,513
-15% -$77.1K ﹤0.01% 1510
2023
Q3
$533K Buy
36,332
+31,354
+630% +$488K ﹤0.01% 1515
2023
Q2
$88.2K Sell
4,978
-1,922
-28% -$32.6K ﹤0.01% 2102
2023
Q1
$123K Sell
6,900
-11,949
-63% -$223K ﹤0.01% 1974
2022
Q4
$369K Sell
18,849
-44,487
-70% -$902K ﹤0.01% 1678
2022
Q3
$1.21M Buy
63,336
+17,468
+38% +$353K ﹤0.01% 1383
2022
Q2
$821K Sell
45,868
-46,062
-50% -$1.08M ﹤0.01% 1469
2022
Q1
$2.65M Buy
91,930
+2,037
+2% +$56K ﹤0.01% 1364
2021
Q4
$2.49M Buy
+89,893
New +$2.54M ﹤0.01% 1436

Other funds holding TBI

Allspring Global Investments's TBI Position: Q2 2024 in Review

Allspring Global Investments sold out of Trueblue (TBI) in Q2 2024, closing a stake of 38,146 shares — an estimated $478K sold.

Allspring Global Investments first reported a position in TBI in Q4 2021 and held it in 10 quarters. The position peaked at $2.65M in Q1 2022. 121 funds tracked by Wall St. Rank hold TBI as of Q2 2024.

  • Allspring Global Investments reported no remaining Trueblue position as of Q2 2024 after selling out during the quarter.
  • Allspring Global Investments sold 38,146 Trueblue shares in Q2 2024, an estimated $478K.
  • Allspring Global Investments first reported a position in Trueblue in Q4 2021 and held it in 10 quarters.
  • Allspring Global Investments's Trueblue position peaked at $2.65M in Q1 2022.
  • 121 funds tracked by Wall St. Rank held Trueblue as of Q2 2024.

Based on Allspring Global Investments's 13F filing for Q2 2024, filed 26 Jul 2024.